- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Daiichi Sankyo Co Ltd
+ Add to WatchlistDSKYF:US
16.8100 USD 0.5100 3.13%As of 13:05:21 ET on 06/19/2013.
Snapshot for Daiichi Sankyo Co Ltd (DSKYF)
| Open: | 16.7900 | Day's Range: | 16.7900 - 16.8100 | Volume: | 326 |
|---|---|---|---|---|---|
| Previous Close: | 16.3000 | 52wk Range: | 14.8300 - 19.6300 | 1-Yr Rtn: | +11.69% |
Key Statistics for DSKYF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(03/2014) | 15.9777 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (JPY) (ttm) | - |
| Est. EPS (JPY) (03/2014) | 100.1380 |
| Est. PEG Ratio | 5.8101 |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 203 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 3.75% |
| Cash Dividend (JPY) | 30.0000 |
| Last Dividend | 09/26/2013 |
| 5 Year Dividend Growth | 1.35% |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DSKYF
Company Profile & Key Executives for DSKYF
DAIICHI SANKYO COMPANY, LIMITED is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
| Takashi ShodaChairman | Joji NakayamaPresident/CEO |
| Tsutomu UneExecutive Director | Takeshi OgitaSenior Executive Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
DSKYF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page